Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1995
09/06/1995EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor
09/06/1995EP0656782A4 Nutritional product for persons having a neurological injury.
09/06/1995EP0529075B1 Hybrid calcitonin
09/06/1995EP0527768B1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria
09/06/1995EP0509027B1 A process to correct and optimize the composition of a feed
09/06/1995EP0474797B1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
09/06/1995EP0317627B1 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
09/06/1995CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
09/06/1995CN1107891A Human megacaryocyte auxin and its separating purification and gene clone method and application
09/06/1995CN1107857A Cyclic amino acid derivativges
09/06/1995CN1107668A Nutritive liquid diet
09/06/1995CN1029684C Process for preparing dynophine derivative
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis
09/05/1995US5447915 Terminally blocked antiviral peptides
09/05/1995US5447914 Bactericides, fungicides
09/05/1995US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/05/1995US5447912 Injecting the neuropeptides VIP and PHM and an adrenergic blocking agent
09/05/1995US5447911 Antitumor agents
09/05/1995US5447860 Tyrosine kinase
09/05/1995US5447852 DNA encoding cyclophilin C, and recombinant methods employing it
09/05/1995US5447851 DNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cells
09/05/1995US5447840 Receptor of the small rhinovirus receptor group
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
09/05/1995US5447725 Methods for aiding periodontal tissue regeneration
09/05/1995US5447722 Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals
09/05/1995CA2143542A1 Antithrombotic agents
09/05/1995CA2143541A1 Antithrombotic agents
09/05/1995CA2143536A1 Antithrombotic agents
09/05/1995CA2143534A1 Antithrombotic agents
09/05/1995CA2143533A1 Antithrombotic agents
09/05/1995CA2143532A1 Bisulfite adducts of arginine aldehydes
09/05/1995CA1336896C Process for extracting and purifying epidermin
09/05/1995CA1336888C Urease antigen product & process
09/05/1995CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
09/05/1995CA1336886C Phenethanolamine and growth hormone combinations
09/04/1995CA2116924A1 Collagenase activating factor and treatment of mammalian tissue therewith
09/02/1995CA2138607A1 Formulations for orally administered pharmaceutical agents
08/1995
08/31/1995WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof
08/31/1995WO1995023229A1 Transgenic plants for the control of animal parasites
08/31/1995WO1995023226A1 Gene for mycobacterial diaminopimelic acid
08/31/1995WO1995023225A2 Method and reagent for inhibiting the expression of disease related genes
08/31/1995WO1995023223A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995WO1995023222A1 Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
08/31/1995WO1995023217A2 Treatment of diabetes mellitus and insulin receptor signal transduction
08/31/1995WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103?
08/31/1995WO1995023213A1 Reproduction and utilization of functional human tissue
08/31/1995WO1995023167A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin
08/31/1995WO1995023165A1 Platelet growth accelerator
08/31/1995WO1995023164A1 A t cell receptor sequence specifically associated with an immune disease
08/31/1995WO1995023161A1 Growth arrest homeobox gene
08/31/1995WO1995023159A1 Novel bombesin-related peptides
08/31/1995WO1995022991A2 Block copolymers
08/31/1995WO1995022990A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition
08/31/1995WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995WO1995022986A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995WO1995022985A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
08/31/1995WO1995022984A1 Methods and kits for stimulating production of megakaryocytes and thrombocytes
08/31/1995WO1995022983A1 Topical composition for the treatment of aphthous ulcers containing an antimicrobial agent and a corticosteroid
08/31/1995WO1995022982A1 Cyclosporin-containing powder composition
08/31/1995WO1995022981A1 Oral synthetic peptide preparation
08/31/1995WO1995022980A1 Inhibin compositions and methods of use thereof
08/31/1995WO1995022979A1 Method for treating conditions of the eye using polypeptides
08/31/1995WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995WO1995016036A3 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF
08/31/1995DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained
08/31/1995CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103
08/31/1995CA2184098A1 Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
08/31/1995CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995CA2184092A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995CA2183992A1 Method and reagent for inhibiting the expression of disease related genes
08/31/1995CA2183953A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995CA2183863A1 Growth arrest homeobox gene
08/31/1995CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995CA2183766A1 Block copolymers
08/31/1995CA2183556A1 Novel bombesin-related peptides
08/31/1995CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995CA2161682A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition
08/31/1995CA2161343A1 Cyclosporin-containing powder composition
08/30/1995EP0669400A1 Method of diagnosing cancer or precancerous state by analysis of IRF-1-specific RNA
08/30/1995EP0669397A1 Novel protein and gene coding for the same
08/30/1995EP0669394A1 Bifunctional derivatives of Urokinase with improved fibrinolytic activity and Thrombin inhibiting activity
08/30/1995EP0669343A1 Cyclic depsipeptides containing lactic acid with 18 ring atoms as endoparasiticidal agents and process for their preparation
08/30/1995EP0669342A2 Process to isolate and purify vitamin-K dependent proteins
08/30/1995EP0669317A1 Prolineamide derivatives
08/30/1995EP0669134A1 Remedy for wound
08/30/1995EP0669001A1 Determination of peptide motifs on mhc molecules.
08/30/1995EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
08/30/1995EP0668920A1 Methods for converting a, ab, and b blood types to o blood type
08/30/1995EP0668918A1 Disease associated human autoantibodies specific for human thyroid peroxidase
08/30/1995EP0668915A1 Protein allergens of the species cynodon dactylon
08/30/1995EP0668914A1 Crystallization of m-csf
08/30/1995EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
08/30/1995EP0668912A1 THE St-B17 SEROTONIN RECEPTOR
08/30/1995EP0668911A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
08/30/1995EP0668910A1 Human neuropeptide y-y1 receptor
08/30/1995EP0668909A1 Transgenic, cross-linked hemoglobin
08/30/1995EP0668907A1 Glycoprotein ligand for p-selectin and methods of use thereof
08/30/1995EP0668879A1 Truncated insulin-like growth factor binding proteins having mitogenic activity
1 ... 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 ... 3163